ObsEva SA, en liquidation is a Switzerland-based company which provides services in the fields of research, development, manufacture, registration, promotion and marketing of biotechnical and pharmaceutical products.

Employees

Sector

Biotechnology & Medical Research

More about the company

Market Cap	4.1M 3.59M 3.29M 3.07M 5.83M 390M 5.91M 39.56M 15.38M 192M 15.39M 15.06M 661M	P/E 2021	-2.57x	P/E 2022	-0.45x
Enterprise Value	-1.3M -1.13M -1.04M -970K -1.84M -123M -1.87M -12.5M -4.86M -60.65M -4.86M -4.76M -209M	EV / Sales 2021	-	EV / Sales 2022	0.65x
Free-Float	70.16%	Yield 2021 *	-	Yield 2022	-

20/04/23	ObsEva to Suspend Reporting With SEC Following Delisting From Nasdaq	MT
20/04/23	ObsEva to Change Central Securities Depositary to SIX SIS; Shares Up 9%	MT
11/04/23	Insider Buy: Obseva	MT
05/04/23	ObsEva SA announced that it has received CHF 0.344 million in funding	CI
31/03/23	ObsEva SA Reports Earnings Results for the Full Year Ended December 31, 2022	CI
30/03/23	ObsEva SA Auditor Raises 'Going Concern' Doubt	CI
22/03/23	ObsEva SA(OTCPK:OBSV.F) dropped from NASDAQ Composite Index	CI
15/03/23	ObsEva to Delist from Nasdaq, Deregister from US SEC	MT
13/03/23	ObsEva Names New CEO From May, Appoints Interim Chairman	MT
13/03/23	ObsEva Names New Interim Chairman, CEO as Reorganization Continues	MT
13/03/23	ObsEva SA Announces CEO Changes, Effective on or About May 1, 2023	CI
13/03/23	ObsEva SA Announces Executive Changes	CI
03/03/23	Top Premarket Gainers	MT

30/08/22	HC Wainwright Downgrades ObsEva to Neutral from Buy	MT
01/08/22	Canaccord Genuity Downgrades ObsEva to Hold From Buy, Adjusts Price Target to $1 From $12	MT
29/07/22	Cantor Fitzgerald Cuts ObsEva to Neutral From Overweight, Price Target to $1 From $6	MT
03/06/22	Cantor Fitzgerald Starts ObsEva at Overweight With $6 Price Target	MT
26/04/22	Canaccord Genuity Starts ObsEva at Buy With $12 Price Target	MT

20/04/23	ObsEva Announces Change of Central Securities Depositary	GL
20/04/23	ObsEva Announces Change of Central Securities Depositary	GL
31/03/23	ObsEva Files Year End 2022 Financial Statements	GL
22/03/23	OBSEVA SA : Other Events (form 8-K)	AQ
15/03/23	ObsEva : Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange - Form 8-K	PU

20/04/23	Obseva-Aktien erhalten im Zuge von Nasdaq-Dekotierung neue ISIN-Nummer
06/04/23	Bourse Zurich: le SMI maintient ses gains à l'approche de la mi-journée
06/04/23	Bourse Zurich: ouverture en hausse avant le long week-end pascal
31/03/23	Obseva bleibt 2022 tief in den roten Zahlen
31/03/23	Obseva reste profondément en rouge en 2022, doutes sur la suite

ObsEva SA Share Price Swiss Exchange

Stocks

OBSN

CH1260041939

Biotechnology & Medical Research

Valuation: ObsEva SA

Latest news : ObsEva SA

Analysts' recommendations: ObsEva SA

Press Releases: ObsEva SA

News in other languages: ObsEva SA

Quotes and Performance

Bio Therapeutic Drugs

Financials

Company Profile

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
OBSEVA SA	-76.92%	-86.36%	-	-	11.72K
ARGENX SE	+0.68%	+5.92%	+77.86%	+139.22%	59.1B
WUXI APPTEC CO., LTD.	+2.32%	+5.03%	+75.26%	+91.40%	55.19B
BIONTECH SE	+3.86%	+6.93%	-11.32%	-9.53%	24.67B
INSMED INCORPORATED	+4.30%	+7.95%	+14.11%	+437.83%	24.19B
WUXI BIOLOGICS (CAYMAN) INC.	+4.74%	+13.68%	+43.36%	-4.67%	19.69B
GENMAB A/S	-0.29%	+9.78%	+43.90%	-28.41%	17.56B
PHARMAESSENTIA CORPORATION	0.00%	+20.78%	+186.15%	+361.42%	16.22B
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	+6.72%	+19.38%	+37.85%	-	14.84B
EXELIXIS, INC.	+3.50%	+1.97%	+21.02%	+191.95%	14.04B
Average	-5.11%	+8.57%	+54.24%	+147.40%	27.28B
Weighted average by Cap.	+2.46%	+6.47%	+58.32%	+136.98%

	2021	2022
Net sales	-	19.64M 17.17M 15.78M 14.71M 27.89M 1.87B 28.31M 189M 73.63M 919M 73.71M 72.13M 3.17B
Net income	-58.38M -51.03M -46.9M -43.72M -82.92M -5.56B -84.17M -563M -219M -2.73B -219M -214M -9.41B	-29.88M -26.12M -24M -22.37M -42.44M -2.84B -43.08M -288M -112M -1.4B -112M -110M -4.82B
Net Debt	-28.08M -24.54M -22.56M -21.02M -39.88M -2.67B -40.48M -271M -105M -1.31B -105M -103M -4.53B	-5.4M -4.72M -4.34M -4.04M -7.67M -514M -7.78M -52.05M -20.24M -253M -20.26M -19.82M -870M